Schneider Eugene

Track

Insider profile

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 47% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Schneider Eugene's trades of Ionis Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-30 2026-06-26
PlS Planned sale
90,438 +13.0%
16.54
US$4,158,363 		90,438 +13.0% 16.54 US$4,158,363
2026-06-26 2026-06-26
PrS Proposed sale
50,333
495.95
US$1,980,201 		50,333 495.95 US$1,980,201
2026-03-24 2026-03-19
PrS Proposed sale
86,988
44.99
US$1,218,377 		86,988 44.99 US$1,218,377
2026-03-23 2026-03-19
PlS Planned sale
5,812 -8.3%
70.97
US$412,486 		5,812 -8.3% 70.97 US$412,486
2026-03-19 2026-03-19
PrS Proposed sale
5,812
70.97
US$412,486 		5,812 70.97 US$412,486
2026-02-02 2026-01-30
S Sale
6,179 -8.1%
83.45
US$515,630 		6,179 -8.1% 83.45 US$515,630
2026-01-30 2026-01-30
PrS Proposed sale
6,179
83.01
US$512,906 		6,179 83.01 US$512,906
2026-01-20 2026-01-16
S Sale
9,302 -12.7%
75.59
US$703,138 		9,302 -12.7% 75.59 US$703,138
2026-01-16 2026-01-16
PrS Proposed sale
9,302
76.23
US$709,072 		9,302 76.23 US$709,072
2025-09-04 2025-09-03
PlS Planned sale
7,203 -12.3%
61.42
US$442,382 		7,203 -12.3% 61.42 US$442,382
2025-09-04 2025-09-03
PlS Planned sale
12,455 -17.5%
60.46
US$753,039 		12,455 -17.5% 60.46 US$753,039
2025-09-03 2025-09-03
PrS Proposed sale
19,658
60.81
US$1,195,421 		19,658 60.81 US$1,195,421
2025-08-05 2025-08-04
PlS Planned sale
9,549 -15.6%
42.80
US$408,701 		9,549 -15.6% 42.80 US$408,701
2025-08-04 2025-08-04
PrS Proposed sale
9,549
42.88
US$409,461 		9,549 42.88 US$409,461
2025-02-03 2025-01-31
S Sale
1,484 -2.4%
32.20
US$47,780 		1,484 -2.4% 32.20 US$47,780
2025-01-31 2025-01-31
PrS Proposed sale
1,700
33.00
US$56,100 		1,700 33.00 US$56,100
2025-01-17 2025-01-16
S Sale
6,523 -10.0%
32.79
US$213,889 		6,523 -10.0% 32.79 US$213,889
2025-01-16 2025-01-16
PrS Proposed sale
6,523
32.70
US$213,302 		6,523 32.70 US$213,302
2024-09-04 2024-02-02
PrS Proposed sale
2,106
49.59
US$104,437 		2,106 49.59 US$104,437
2024-02-02 2024-02-02
PrS Proposed sale
2,071
49.59
US$102,701 		2,071 49.59 US$102,701
2024-02-02 2024-02-02
S Sale
2,071 -4.0%
49.59
US$102,701 		2,071 -4.0% 49.59 US$102,701
2024-01-18 2024-01-17
S Sale
5,482 -10.3%
50.42
US$276,386 		5,482 -10.3% 50.42 US$276,386
2024-01-17 2024-01-17
PrS Proposed sale
5,482
50.54
US$277,058 		5,482 50.54 US$277,058
2024-01-17 2024-01-12
S Sale
8,000 -17.3%
53.50
US$427,999 		8,000 -17.3% 53.50 US$427,999
2024-01-12 2024-01-12
PrS Proposed sale
8,000
53.50
US$428,000 		8,000 53.50 US$428,000
2023-12-28 2023-12-26
S Sale
25,000 -40.9%
51.46
US$1,286,575 		25,000 -40.9% 51.46 US$1,286,575
2023-12-27 2023-12-26
PrS Proposed sale
25,000
51.50
US$1,287,500 		25,000 51.50 US$1,287,500
2023-02-07 2023-02-06
PrS Proposed sale
1,413
40.69
US$57,498 		1,413 40.69 US$57,498
2023-02-07 2023-02-06
S Sale
1,413 -5.4%
40.67
US$57,464 		1,413 -5.4% 40.67 US$57,464
2023-01-19 2023-01-18
PrS Proposed sale
5,400
41.00
US$221,400 		5,400 41.00 US$221,400
2023-01-19 2023-01-18
S Sale
4,752 -17.5%
39.57
US$188,052 		4,752 -17.5% 39.57 US$188,052